Secondary leukemias induced by topoisomerase-targeted drugs
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1400 (1-3) , 233-255
- https://doi.org/10.1016/s0167-4781(98)00139-0
Abstract
No abstract availableKeywords
This publication has 216 references indexed in Scilit:
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Secondary pre-leukaemia and etoposideThe Lancet, 1991
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991
- Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocationGenes, Chromosomes and Cancer, 1990
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Leukemia after Adjuvant Chemotherapy with Semustine (Methyl-CCNU) — Evidence of a Dose–Response EffectNew England Journal of Medicine, 1986
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982